| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/19/2012 | US20120183602 Lipid formulation |
| 07/19/2012 | US20120183601 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha |
| 07/19/2012 | US20120183600 Novel composition for treating metabolic syndrome and other conditions |
| 07/19/2012 | US20120183599 Pharmaceutical Composition |
| 07/19/2012 | US20120183598 Hla-a2 tumor associated antigen peptides and compositions |
| 07/19/2012 | US20120183597 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 07/19/2012 | US20120183596 Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes |
| 07/19/2012 | US20120183595 Transdermal Pharmaceutical Delivery Composition |
| 07/19/2012 | US20120183594 Method of increasing photosynthesis and reducing ozone |
| 07/19/2012 | US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
| 07/19/2012 | US20120183591 Surfactant Mixtures for Improving the Deposition of Active Substances and for Reducing the Skin Irritant Action |
| 07/19/2012 | US20120183589 Lipid Nanoparticles For Gene Therapy |
| 07/19/2012 | US20120183588 High load dispersions |
| 07/19/2012 | US20120183587 Flavonol compositions |
| 07/19/2012 | US20120183586 Method of obtaining viable small tissue particles and use for tissue repair |
| 07/19/2012 | US20120183585 Gel based wound dressing and a method of synthesizing the same |
| 07/19/2012 | US20120183584 Method for preparing a stable oil-in-water emulsion |
| 07/19/2012 | US20120183583 Medical Device With Intrapore Films |
| 07/19/2012 | US20120183582 Oral Delivery of Peptides |
| 07/19/2012 | US20120183581 Novel lipid formulations for nucleic acid delivery |
| 07/19/2012 | US20120183580 Analgesic Composition for Transbuccal Administration |
| 07/19/2012 | US20120183476 Methods of administering liquid droplet aerosols of nanoparticulate drugs |
| 07/19/2012 | US20120181212 Preparation for oral administration |
| 07/19/2012 | CA2824768A1 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
| 07/19/2012 | CA2824484A1 Implant comprising a core and a tube encasing the core |
| 07/19/2012 | CA2824441A1 Compositions comprising crosslinked cation - binding polymers and calcium and/or magnesium cations, and uses thereof |
| 07/19/2012 | CA2824391A1 Compositions comprising crosslinked cation-binding polymers and a base, uses thereof |
| 07/19/2012 | CA2824154A1 Method for delivering agents into cells using bacterial toxins |
| 07/19/2012 | CA2824066A1 Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide |
| 07/19/2012 | CA2823972A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions |
| 07/19/2012 | CA2823783A1 Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
| 07/18/2012 | EP2476753A1 Construct coated with virus coat-constituting protein and method for producing same |
| 07/18/2012 | EP2476726A1 Processing of chitosan and chitosan derivatives |
| 07/18/2012 | EP2476461A2 Formulations For Cancer Treatment |
| 07/18/2012 | EP2476439A1 Aqueous composition for enteric hard capsules, production method for enteric hard capsules and enteric hard capsules |
| 07/18/2012 | EP2476424A1 Orally administrable tablet for intestinal lavage |
| 07/18/2012 | EP2476423A1 Antacid and laxative tablet |
| 07/18/2012 | EP2476420A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same |
| 07/18/2012 | EP2476419A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same |
| 07/18/2012 | EP2476418A1 Pharmaceutical compound and composition for use in treating type II diabetes comprising rosiglitazone in a specific particle size |
| 07/18/2012 | EP2476414A1 Transdermally absorbable preparation |
| 07/18/2012 | EP2476413A1 Liquid composition to be filled in soft capsules |
| 07/18/2012 | EP2476412A1 Apparatus for precipitation of small medicament particles into use containers |
| 07/18/2012 | EP2476411A1 A method of promoting tissue repair |
| 07/18/2012 | EP2476410A1 An analgesic peptide-containing composition for transbuccal administration |
| 07/18/2012 | EP2476409A1 Implant comprising a core and a tube encasing the core |
| 07/18/2012 | EP2476392A1 Post-operative control of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart |
| 07/18/2012 | EP2475430A1 Granulated anthelmintic preparations and delivery systems |
| 07/18/2012 | EP2475396A2 Engineered microparticles for macromolecule delivery |
| 07/18/2012 | EP2475395A2 High strength seamless alginate capsules |
| 07/18/2012 | EP2475394A2 Seamless alginate capsules |
| 07/18/2012 | EP2475382A2 Method of treating eosinophilic esophagitis |
| 07/18/2012 | EP2475379A2 Cd117+cells and uses thereof |
| 07/18/2012 | EP2475359A1 Pharmaceutical formulation containing ribavirin |
| 07/18/2012 | EP2475358A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 07/18/2012 | EP2475357A1 Oral suspension formulations of esclicarbazepine acetate |
| 07/18/2012 | EP2475356A1 Devices, systems and methods for adjusting fluid delivery parameters |
| 07/18/2012 | EP2475355A1 Transdermal patch formulation |
| 07/18/2012 | EP2475354A2 Implantable device for controlled drug delivery |
| 07/18/2012 | EP2475353A2 Highly concentrated pharmaceutical formulations comprising anti-cd20 antibody |
| 07/18/2012 | EP2475352A1 Composition containing ultra-micronized palmitoyl - ethanolamide |
| 07/18/2012 | EP2475316A1 Device to be implanted in a human or animal body for material or signal delivery or acquisition within the body |
| 07/18/2012 | EP2175881B1 Intradermal influenza vaccine |
| 07/18/2012 | EP2118006B1 Method for preparing silica compositions, silica compositions and uses thereof |
| 07/18/2012 | EP1996036B1 Preparing dried particles using a supercritical medium |
| 07/18/2012 | EP1982705B1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application |
| 07/18/2012 | EP1976489B1 Multiple unit type sustained release oral formulation comprising zaltoprofen and process for the preparation thereof |
| 07/18/2012 | EP1931346B1 Trazodone composition for once a day administration |
| 07/18/2012 | EP1901717B1 Orally disintegrating powder comprising cilostazol and mannitol |
| 07/18/2012 | EP1884234B1 Prophylactic or therapeutic agent for corneal and conjunctival disorder |
| 07/18/2012 | EP1809243B1 Aerosol suspension formulations containing tg 227 ea as a propellant |
| 07/18/2012 | EP1669065B1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 07/18/2012 | EP1389909B1 Antimicrobial compounds and methods for their use |
| 07/18/2012 | CN202336064U 一种感冒外用贴 One kind of cold topical paste |
| 07/18/2012 | CN202336063U 一种软胶囊 A soft capsule |
| 07/18/2012 | CN1913877B Rapidly disintegrating gelatinous coated tablets |
| 07/18/2012 | CN1903214B Ointment containing red precipitate |
| 07/18/2012 | CN1794983B Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 07/18/2012 | CN1473035B Compositions containing substained-release fine grains for tablets quickly disintegrable in oral cavity and process for producing same |
| 07/18/2012 | CN102597149A Process for the continuous manufacture of a polyisobutylene based transdermal patch |
| 07/18/2012 | CN102596438A Destructive disposal of medical active ingredients in transdermal therapeutic systems |
| 07/18/2012 | CN102596253A Mucoadhesive polymers having vitamin B partialstructures |
| 07/18/2012 | CN102596252A Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 07/18/2012 | CN102596251A High strength seamless alginate capsules |
| 07/18/2012 | CN102596244A 丙型肝炎病毒疫苗组合物 HCV vaccine composition |
| 07/18/2012 | CN102596206A Pharmaceutical composition for oral administration |
| 07/18/2012 | CN102596195A Water-based paste containing diclofenac sodium |
| 07/18/2012 | CN102596193A Dermal formulations of DP2 receptor antagonists |
| 07/18/2012 | CN102596187A Carbohydrate entrapped active agent delivery composition and articles using the same |
| 07/18/2012 | CN102596186A Core stabilized microcapsules, method of their preparation and uses thereof |
| 07/18/2012 | CN102596185A An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation |
| 07/18/2012 | CN102596184A (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability |
| 07/18/2012 | CN102596183A Fast dissolving/disintegrating coating compositions |
| 07/18/2012 | CN102596182A Use of biocompatible compositions and materials polymerized therefrom for inhibiting angiogenesis |
| 07/18/2012 | CN102596181A Anti-misuse solid oral dosage form provided having a modified specific release profile |
| 07/18/2012 | CN102596180A Anti-viral composition and method |
| 07/18/2012 | CN102596179A Liposomal compositions and uses of same |
| 07/18/2012 | CN102596177A Microvesicles derived from nucleated, mammalian cells and use thereof |
| 07/18/2012 | CN102596176A Compositions for respiratory delivery of active agents and associated methods and systems |
| 07/18/2012 | CN102596175A Aqueous insulin preparations containing methionine |